Instructions for Tolterodine L‑Tartrate SR capsules, including dosage, indications, side effects and storage.
This leaflet provides detailed information on Tolterodine L‑Tartrate Sustained Release Capsules, a medication used to treat overactive bladder symptoms such as urgency, frequency and urge incontinence. It includes the drug’s generic and English names, chemical composition, appearance, therapeutic indications, and available strengths (2 mg and 4 mg).
The document also covers recommended dosing, adjustments for special populations (renal or hepatic impairment, concomitant CYP inhibitors), contraindications, warnings, adverse reactions, drug interactions, overdose handling, and storage conditions. Contact information for the manufacturer and packaging company is provided at the end. This manual is written in Chinese.
| 化学式 | C26H37NO7 |
|---|---|
| 分子量 | 475.6 |
| 剂型 | 硬胶囊 |
| 规格 | 2 mg, 4 mg |
The most frequently reported side effects are dry mouth, headache, constipation and abdominal pain.
No, it is not recommended for patients with severe liver impairment (Child‑Pugh class C).